Figure 3
Figure 3. Differentially expressed probe sequences in tumor and pretumor B cells. Data analysis was performed using GeneSpringGX software. Probes were included if the fold change was greater than 1.5 and false discovery rate (adjusted P value) < .05. (A) A total of 199 probe sequences are differentially expressed in pretumor B cells. The 199 probes correspond to 187 unique genes, 77 are up-regulated in the LMP2A/λ-MYC samples, and 110 are down-regulated in the LMP2A/λ-MYC samples. (B) Nineteen probe sequences are differentially expressed in cervical lymph node tumor samples. The 19 probes correspond to 17 unique genes, 12 are up-regulated in the LMP2A/λ-MYC samples, and 5 are down-regulated in the LMP2A/λ-MYC samples.

Differentially expressed probe sequences in tumor and pretumor B cells. Data analysis was performed using GeneSpringGX software. Probes were included if the fold change was greater than 1.5 and false discovery rate (adjusted P value) < .05. (A) A total of 199 probe sequences are differentially expressed in pretumor B cells. The 199 probes correspond to 187 unique genes, 77 are up-regulated in the LMP2A/λ-MYC samples, and 110 are down-regulated in the LMP2A/λ-MYC samples. (B) Nineteen probe sequences are differentially expressed in cervical lymph node tumor samples. The 19 probes correspond to 17 unique genes, 12 are up-regulated in the LMP2A/λ-MYC samples, and 5 are down-regulated in the LMP2A/λ-MYC samples.

Close Modal

or Create an Account

Close Modal
Close Modal